Biotechnology - Biotechnology, Management

Filter

Current filters:

BiotechnologyManagement

Popular Filters

1 to 25 of 40 results

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

Amgen’s 2nd-qtr beats expectations, but firm slashes workforce

30-07-2014

Amgen, the largest global independent biotech firm, reported a 23% leap in second-quarter 2014 profit…

AmgenBiotechnologyFinancialManagement

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Affymax decides to wind up company following demise of Omontys

Affymax decides to wind up company following demise of Omontys

25-06-2014

USA-based biotech firm Affymax says that its board of directors has approved the liquidation and dissolution…

AffymaxBiotechnologyFinancialManagementOmontysOncologyTakeda Pharmaceutical

ThromboGenics plans to remain independent

24-06-2014

In response to market rumors, Belgian biotech firm ThromboGenics today issues an update on the Strategic…

BiotechnologyJetreaManagementOphthalmicsThromboGenics

Big pharma becomes a smaller employer while biotech booms

Big pharma becomes a smaller employer while biotech booms

19-06-2014

Big pharma employment dropped by 3% in the decade 2003-2013, allaying fears that industry consolidation…

BiotechnologyManagementPharmaceutical

Dendreon chief to step down for personal reasons

Dendreon chief to step down for personal reasons

10-06-2014

US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and…

BiotechnologyBoardroomDendreonManagementProvenge

Biota Pharma plans restructuring following loss of BARDA contract

02-06-2014

USA-based Biota Pharmaceuticals has adopted a plan to restructure the company's operations following…

Anti-viralsBiota PharmaceuticalsBiotechnologyFinanciallaninamivirManagementUSA

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech

11-03-2014

Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…

Asia-PacificAustraliaBiotechnologyChinaManagementResearch

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Domain Therapeutics opens North American subsidiary

20-01-2014

French biopharma company Domain Therapeutics, specializing in the R&D of new drug candidates targeting…

BiotechnologyCanadaDomain TherapeuticsManagementNorth America

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

Big news day for Amicus, with change in GSK deal, an acquisition and restructuring

Big news day for Amicus, with change in GSK deal, an acquisition and restructuring

22-11-2013

US biotech firm Amicus Therapeutics saw its shares fall 4.2% to $2.03 by mid-morning trading on Thursday,…

Amicus TherapeuticsBiotechnologyCallidus BiopharmaFinancialGlaxoSmithKlineLicensingManagementMergers & AcquisitionsmigalastatRare diseases

AVEO Oncology restructuring and job cuts as tivozanib future in RCC in doubt

05-06-2013

Following a recent negative opinion on its lead product candidate from a Food and Drug Administration…

Astellas PharmaAVEO OncologyBiotechnologyFinancialManagementOncologyResearchtivozanib

Exec appointments at Biogen Idec and Halozyme; Succession plan for Forest Labs

23-05-2013

US biotech firm Biogen Idec (Nasdaq: BIIB) announced that Spyros Artavanis-Tsakonas, has been named chief…

Biogen IdecBiotechnologyForest LaboratoriesHalozyme TherapeuticsManagementPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Aastrom Biosciences to re-focus on DCM program, and cut workforce

28-03-2013

US cardiovascular drug developer Aastrom Biosciences (NasdaqCM: ASTM) has announced a strategic change…

Aastrom BiosciencesBiotechnologyCardio-vascularixmyelocel-TManagementResearch

Affymax slashes workforce following Omontys problems; evaluating options

19-03-2013

US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…

AffymaxBiotechnologyFinancialManagementOmontysOncologyPharmaceutical

CoCo Therapeutics created in UK to progress retinoic acid receptor alpha agonist for Alzheimer's

07-03-2013

King's College London, The Wellcome Trust and Advent Venture Partners have announced the formation of…

BiotechnologyCoCo TherapeuticsFinancialManagementResearch

Roche granted EU approval for Perjeta; board appointments

06-03-2013

The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…

BiotechnologyEuropeManagementOncologyPerjetaPharmaceuticalRegulationRoche

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds

04-02-2013

A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

BioCryst Pharma restructures in face of pipeline disappointments

10-12-2012

USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX), whose merger with Presidio was called off earlier…

BCX4161BCX5191BioCryst PharmaceuticalsBiotechnologyFinancialManagementperamivirResearchulodesine

Drugmakers spend an average $237,000 per medical science liaison in the USA

31-10-2012

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

1 to 25 of 40 results

Back to top